Cord Blood

Infant Receives Genetically Modified Cryopreserved Cord Blood

Published in Gene Therapy Weekly, April 21st, 1997

In an effort to prevent the same fate that befell a dead sibling, an Israeli-Italian research team has transplanted an infant with genetically modified cryopreserved cord blood.

This is the first time that cryopreserved cord blood has been genetically modified and used in a clinical setting.

Shimon Slavin, Arnon Nagler, and Elizabeth Naparstek from the Hadassah Medical Center, Jerusalem, Israel, and Claudio Bordignon and Alessandro Aiuti, from the HS Raffaele Scientific Institute, Milan, Italy, collaborated on the procedure. As reported by Rachelle H.B. Fishman in The Lancet ("Frozen Cord Blood Used for Human Gene Therapy," March 8,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1997-04-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry